Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bittium Oyj Board/Management Information 2025

Mar 6, 2025

3258_rns_2025-03-06_2061a937-e005-439b-8054-1a577766ae72.html

Board/Management Information

Open in viewer

Opens in your device viewer

Change in Bittium Corporation's Management Group: Niina Huikuri Appointed as Senior Vice President, Medical Business Segment

Change in Bittium Corporation's Management Group: Niina Huikuri Appointed as Senior Vice President, Medical Business Segment

Bittium Corporation
Changes Board/Management/Auditors

Change in Bittium Corporation's Management Group: Niina Huikuri Appointed as
Senior Vice President, Medical Business Segment

Bittium Corporation, Stock Exchange Release, March 6, 2025, at 8.15 am (CET+1)

Niina Huikuri (Ms.Econ) has been appointed as Senior Vice President, Medical
Business Segment and a member of Bittium Corporation's management group as of
May 1, 2025. She will report to the CEO of Bittium Corporation. Laura Kauppinen,
the current Senior Vice President, Medical Business Segment and a member of
Bittium Corporation's management group has resigned from her position. She will
continue in her position until April 30, 2025.

Niina Huikuri has over 20 years of international commercial experience in the
medical devices sector. She joins Bittium from her current position as Chief
Commercial Officer of Askel Healthcare Ltd. Prior to her current role, she has
worked in various management positions e.g. in Optomed and Johnson & Johnson,
leading business development, product management as well as sales and marketing
of medical sector products and services. She has experience in building
international sales channels in the health technology sector, as well as
successful commercialization of medical devices in the US.

“I am happy to be able to welcome Niina to Bittium to build international growth
in the Medical Business Segment. Niina has a solid track record in
commercializing medical devices and in developing businesses in global markets.
The Medical business will focus on international sales growth, implementation of
customer-centric operating models in the organization, and increasing
competitiveness in the upcoming strategy period,” says Petri Toljamo, member of
the Board of Directors of Bittium Corporation. “On behalf of the entire company,
I would like to thank Laura for the implementation of various processes to
improve profitability in Bittium group. Under Laura's leadership in Medical
Business Segment, the organization's expertise has been significantly
strengthened, and operational efficiency has been improved to enable the
implementation of a profitable growth strategy.”

Oulu, Finland
March 6, 2025

Bittium Corporation
The Board of Directors

Further Information:

Karoliina Malmi
Vice President, Communications & Sustainability
Tel. +358 40 344 2789

Distribution

NASDAQ Helsinki
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and
connectivity solutions leveraging its 40-year legacy of expertise in advanced
radio communication technologies. Bittium provides innovative products and
services, customized solutions based on its product platforms and R&D services.
Complementing its communications and connectivity solutions, Bittium offers
proven information security solutions for mobile devices and portable computers.
Bittium also provides healthcare technology products and services for biosignal
measuring in the areas of cardiology and neurophysiology. Net sales in 2024 were
EUR 85.2 million and operating profit EUR 8.6 million. Bittium is listed on
Nasdaq Helsinki. www.bittium.com

Attachments: